Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calroy Health Sciences develops science-based dietary supplements focused on cardiovascular and foundational health. Its flagship product Arterosil HP contains a patented seaweed extract shown in preclinical studies to protect the endothelial glycocalyx. Vascanox HP supports nitric oxide production for vascular benefits. The company invests in research and has established a Science & Medical Advisory Board but does not conduct pharmaceutical clinical trials or have FDA-approved drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calroy Health Sciences.